8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Apr 21, 2005)

Filed April 21, 2005For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed a Form 8-K on April 21, 2005, to announce its financial results for the first quarter ended April 20, 2005. This report primarily serves to furnish the press release containing these results, which is attached as Exhibit 99.1. Investors should refer to this press release for detailed financial performance, operational highlights, and any forward-looking statements made by the company for the period. The filing indicates that the press release contains the company's financial results for the first quarter of 2005. While the 8-K itself does not contain the detailed financial figures, it formally incorporates the press release by reference. A portion of the press release, specifically the first two paragraphs and pages 6 through 11, are deemed 'filed' with the SEC for purposes of Section 18 of the Exchange Act, meaning they are subject to liability for misstatements. Other parts of the press release are furnished but not filed.

Key Highlights

  • 1Edwards Lifesciences announced its first quarter 2005 financial results via press release on April 21, 2005.
  • 2The 8-K filing primarily serves as a vehicle to provide the market with these Q1 2005 earnings.
  • 3Exhibit 99.1, the press release, contains the specific financial results and operational details for the quarter.
  • 4Certain sections of the press release (first two paragraphs and pages 6-11) are considered 'filed' under the Exchange Act, subject to liability.
  • 5The Chief Financial Officer, Corinne H. Lyle, signed the report.
  • 6The filing confirms Edwards Lifesciences Corporation is incorporated in Delaware.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disseminate Edwards Lifesciences Corporation's financial results for the first quarter of 2005, as detailed in an accompanying press release (Exhibit 99.1).

The actual financial results for the first quarter of 2005 are located within the press release attached as Exhibit 99.1 to this 8-K filing. Investors will need to review this exhibit for specific revenue, profit, and other financial performance data.

No, not all details are equally subject to liability. According to the filing, only the information contained in the first two paragraphs of Exhibit 99.1 and pages 6 through 11 of the press release are deemed 'filed' under the Exchange Act and thus subject to liability for misstatements. Other portions are furnished but not filed.

Edwards Lifesciences issued the press release reporting these financial results on April 21, 2005, and the 8-K filing was made on the same date.